Back in the Neutral Zone

With an afternoon push lower, biotechnology stocks in the IBB ETF cracked back under $290, their prior breakout level. 

On the IBB daily chart, below, note the uptick in sell volume on the move. I am sure MYL in the news today is not helping the cause. But the INSY downside reversal is not pretty, either. 

Overall, upside momentum in the market continues to clearly cool off. I am not turning super bearish here, though backing off the long side until we see things firm up makes sense. 

More in my recaps after the bell.